Following our report last month on the $130bn mega-merger between US chemical giants Dow Chemical and DuPont, a new deal has announced the creation of a chemicals giant with a market value of approx $14 billion. This latest high-profile transaction across the diversified chemicals sector sees companies are striking ever more aggressive deals to find new ways to slash costs and gain greater scale of their segments, typifying the current market trend for companies to cut costs and boost revenue.
READ MORE >>Archives
Chemicals Sector Continues to Remain Buoyant
Dow and DuPont get EU go-ahead
The $130bn mega-merger between US chemical giants Dow Chemical and DuPont has been given the go-ahead by the European Commission. Earlier this year, it was announced that the deal would be subject to an investigation from EU competition regulators due to antitrust concerns.
READ MORE >>Share this:
Dow and DuPont subject to antitrust concerns
The mega-merger between chemicals and seeds producer DuPont and chemical corporation Dow is now expected to close later than anticipated. The $130bn deal has encountered a roadblock as the companies face further regulatory approvals, which means that this is now the second occasion the deal’s completion date has been pushed back.
READ MORE >>Share this:
M&A Activity Hits an All Time High
The corporate industry world has borne witness to some of the mega deals being signed throughout the year. Pharmaceutical giant Pfizer announced as $160 billion merger with Allergan. A deal that was, according to Bloomberg, “the largest ever deal in the history of healthcare industry and second biggest deal overall on record”.
READ MORE >>